Granulocyte colony-stimulating factor in the combination chemotherapy for adult T-cell leukemia (ATL)

Leukemia and Lymphoma

Volumn 29, Issue 3-4, 1998, Pages 407-414

  Uozumi, Kimiharu ^a   Nakahara, Katsushi ^a   Takatsuka, Yoshifusa ^a   Ohno, Nobuhito ^a   Makino, Torahiko ^a   Utsunomiya, Atae ^a   Hanada, Shuichi ^a   Arima, Terukatsu ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

ATL; G CSF; RCM protocol; Standard dose chemotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; MITOMYCIN C; PEPLEOMYCIN; PIRARUBICIN; PREDNISOLONE; RANIMUSTINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINDESINE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CLINICAL PROTOCOL; FEMALE; HUMAN; INFECTIOUS COMPLICATION; MALE; NEUTROPENIA; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; T CELL LEUKEMIA;

EID: 0031816496     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199809068577     Document Type: Article

References (36)

1. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. and Uchino, H. (1977). Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood, 50, 481-492.
2. Poiesz, B. J., Ruscetti, F. W., Gazdar, A. F., Bunn, P. A., Minna, J. D. and Gallo, R. C. (1980). Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA, 77, 7415-7419.
3. Shimoyama, M., Ota, K., Kikuchi, M., Yunoki, K., Konda, S., Takatsuki, K., Ichimaru, M., Ogawa, M., Kimura, I., Tominaga, S., Tsugane, S., Taguchi, H., Minato, K., Takenaka, T., Tobinai, K., Kurita, S., Oyama, A., Hisano, S., Kozuru, M., Matsumoto, M., Nomura, K., Takiguchi, T., Sugai, S., Yamaguchi, K., Hattori, T., Kinoshita, K., Tajima, K. and Suemasu, K. for the Lymphoma Study Group (1981-1983). (1988). Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol, 6, 128-141.
4. Makino, T., Uozumi, K., Shimazaki, T., Otsuka, M., Kuwazuru, Y., Saito, T., Utsunomiya, A., Hanada, S. and Hashimoto, S. (1988). Combination chemotherapy for adult T-cell leukemia (ATL) using Cyclophosphamide, Vindesine, and Prednisolone (CVP). J Jpn Soc Cancer Ther, 23, 2657-2662.
5. Shimamoto, Y., Suga, K., Shimojo, M., Nishimura, J., Nawata, H. and Yamaguchi, M. (1990). Comparison of CHOP versus VEPA therapy in patients with lymphoma type of adult T-cell leukemia. Leuk & Lymphoma, 2, 335-240.
6. Lymphoma Study Group (1984-1987). (1991). Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leuk Res, 15, 81-90.
7. Lofters, W., Campbell, M., Gibbs, W. N. and Cheson, B. D. (1987). 2′-Deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer, 60, 2605-2608.
8. Ohno, R., Masaoka, T., Shirakawa, S., Sakamoto, S., Hirano, M., Hanada, S., Yasunaga, K., Yokomaku, S., Mitomo, Y., Nagai, K., Yamada, K. and Furue, H. for the MST-16 Study Group. (1993). Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumor drug and a derivative of Bis(2,6-dioxopiperazine). Cancer, 71, 2217-2221.
9. Waldmann, T. A., White, J. D., Carrasquillo, J. A., Reynolds, J. C., Paik, C. H., Gansow, O. A., Brechbiel, M. W., Jaffe, E. S., Fleisher, T. A., Goldman, C. K., Top, L. E., Bamford, R., Zaknoen, S., Roessler, E., Kasten-Sportes, C., England, R., Litou, H., Johnson, J. A., Jackson-White, T., Manns, A., Hanchard, B., Junghans, R. P. and Nelson, D. L. (1995). Radioimmunotherapy of interleukin-2Rα-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood, 86, 4063-4075.
10. Gill, P. S., Harrington, W., Kaplan, M. H., Ribeiro, R. C., Bennet, J. M., Liebman, H. A., Bernstein-Singer, M., Espina, B. M., Cabrai, L., Allen, S., Komblau, S., Pike, M. C. and Levine, A. M. (1995). Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med, 332, 1744-1748.
11. Borg, A., Liu Yin J., Johnson, P. R. E., Tosswill, J., Saunders, M. and Morris, D. (1996). Successful treatment of HTLV-I-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. Br J Haematol, 94, 713-715.
12. Shimoyama, M. and members of The Lymphoma Study Group (1984-87). (1991). Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma; a report from the lymphoma study group (1984-87). Br J Haematol, 79, 428-437.
13. Uozumi, K., Hanada, S., Ohno, N., Ishitsuka, K., Shimotakahara, S., Otsuka, M., Chyuman, Y., Nakahara, K., Takeshita, T., Kuwazuru, Y., Saito, T., Makino, T., Iwahashi, M., Utsunomiya, A. and Arima, T. (1995). Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia. Leuk & Lymphoma, 18, 317-323.
14. Matsumoto, M., Nomura, K., Matsumoto, T., Nishioka, K., Hanada, S., Furusho, H., Kikuchi, H., Kato, Y., Utsunomiya, A., Uematsu, T., Iwahashi, M., Hashimoto, S. and Yunoki, K. (1979). Adult T-cell leukemia-lymphoma in Kagoshima district, southwestern Japan: clinical and hematological characteristics. Jpn J Clin Oncol, 9 (suppl.), 325-336.
15. Kawano, F., Yamaguchi, K., Nishimura, H., Tsuda, H. and Takatsuki, K. (1985). Variation in the clinical courses of adult T-cell leukemia. Cancer, 55, 851-856.
16. Oken, M. M., Creech, R. H., Tormey, D. C., Horton, J., Davis, T. E., McFadden, E. T. and Carbone, P. P. (1982). Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 5, 649-655.
17. Lister, T. A., Crowther, D., Sutcliffe, S. B., Glatstein, E., Canellos, G. P., Young, R. C., Rosenberg, S. A., Coltman, C. A. and Tubiana, M. (1989). Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotsworlds meeting. J Clin Oncol, 7, 1630-1636.
18. Oyama, A., Ota, K., Asano, S., Takaku, F., Miyazaki, T., Uzuka, Y., Omine, M., Furusawa, S., Hirashima, K., Sanpi, K., Takatani, O., Sawada, U., Nomura, T., Toyama, K., Aoki, N., Mori, M., Matsuda, T., Saito, H., Hirano, M., Masaoka, T., Kimura, I., Dohi, H., Toki, H., Niho, Y., Tomonaga, M., Takatsuki, K. and Ogawa, N. (1990). Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy of non-Hodgkin's lymphoma. J Jpn Soc Cancer Ther, 25, 1619-1634. (In Japanese.)
19. Ogawa, M., Masaoka,T. and Takaku, F. (1990). Phase II study of KRN 8601 in patients with neutropenia induced by chemotherapy of malignant lymphoma-subcutaneous administration-. Rinsho lyaku, 6, 23-40. (In Japanese.)
20. Uozumi, K., Hanada, S. and Arima, T. (1994). Elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia complicated with meningeal infiltration. Br J Haematol, 87, 643-646.
21. Uozumi, K., Ishitsuka, K., Ohno, N., Nakahara, K., Utsunomiya, A., Hanada, S. and Arima, T. (1995). Significance of elevated levels of soluble factors in the cerebrospinal fluid in patients with adult T-cell leukemia. Leuk & Lymphoma, 19, 437-445.
22. Miller, A. B., Hoogstraten, B., Staquet, M. and Winkler, A. (1981). Reporting results of cancer treatment. Cancer, 47, 207-214.
23. Tobinai, K., Kohno, A., Shimada, Y., Watanabe, T., Tamura, T., Takeyama, K., Narabayashi, M., Fukutomi, T., Kondo, H., Shimoyama, M., Suemasu, K. and members of the clinical trial review committee of the Japan clinical oncology group. (1993). Toxicity grading criteria of the Japan clinical oncology group. Jpn J Clin Oncol, 23, 250-257.
24. Kaplan, E. L. and Meier, P. (1958). Nonparametric estimation from incomplete observations. J Am Stat Assoc, 53, 151-158.
25. Tsukasaki, K., Ikeda, S., Murata, K., Maeda, T., Atogami, S., Sohda, H., Momita, S., Jubashi, T., Yamada, Y., Mine, M., Kanuhira, S. and Tomonaga, M. (1993). Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk Res, 17, 157-166.
26. Weite, K., Gabrilove, J., Bronchud, M. H., Platzer, E. and Morstyn, G. (1996). Filgrastim (r-metHuG-CSF): The first 10 years. Blood, 88, 1907-1929.
27. Neidhart, J. A. (1992). Hematopoietic colony-stimulating factors. Uses in combination with standard chemotherapeutic regimens and in support of dose intensification. Cancer, 70, 913-920.
28. Elihu, H. E. (1994). Use of colony-stimulating factors in the treatment of acute myeloid leukemia. Blood, 83, 2015-2019.
29. Ohno, R., Naoe, T., Kanamaru, A., Yoshida, M., Hiraoka, A., Kobayashi, T., Ueda, T., Minami, S., Morishima, Y., Saito, Y., Furusawa, S., Imai, K., Takemoto, Y., Miura, Y., Teshima, H., Hamajima, M. and the Koseisho Leukemia Study Group. (1994). A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood, 83, 2086-2092.
30. Stone, R. M., Berg, D. T., George, S. L., Dodge, R. K., Paciucci, P. A., Schulman, P., Lee, E. J., Moore, J. O., Powell, B. L. and Schiffer, C. A. for the cancer and leukemia group B. (1995). Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N Engl J Med, 332, 1671-1677.
31. Dombret, H., Chastang, C., Fenaux, P., Reiffers, J., Bordessoule, D., Bouabdallah, R., Mandelli, F., Ferrant, A., Auzanneau, G., Tilly, H., Yver, A., Degos, L., for the AML cooperative study group. (1995). A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myelogenous leukemia. N Engl J Med, 332, 1678-1683.
32. Stahel, R. A., Jost, L. M., Cerny, T., Pichert, G., Honegger, H., Tobler, A., Jacky, E., Fey, M. and Platzer, E. (1994). Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies. J Clin Oncol, 12, 1931-1938.
33. Ottmann, O. G., Hoelzer, D., Gracien, E., Ganser, A., Kelly, K., Reutzel, R., Lipp, T., Busch, F. W., Schwonzen, M., Heil, G., Wandt, H., Koch, P., Kolbe, K., Heyll, A., Bentz, M., Peters, S., Diedrich, H., Dethling, J., Meyer, P., Nowrousian, M. R., Löffler, B., Weiss, A., Kneba, M., Föller, A., Graf, M. and Hecht, T. (1995). Concomitant granulocyte colony-stimulating factor and induction chemoradiotherapy in adult acute lymphoblastic leukemia: A randomized phase IFI trial. Blood, 86, 444-450.
34. Taguchi, H., Kinoshita, K., Takatsuki, K., Tomonaga, M., Araki, K., Arima, N., Ikeda, S., Uozumi, K., Kohno, H., Kawano, F., Kikuchi, H., Takahashi, H., Tamura, K., Chiyoda, S., Tsuda, H., Nishimura, H., Hosokawa, T., Matsuzaki, H., Momita, S., Yamada, O. and Miyoshi, I. (1996). An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol, 12, 182-186.
35. Shimoyama, M. (1994). Chemotherapy of ATL. In Adult T-cell Leukaemia, (ed.) K. Takatsuki, pp. 221-237. (Oxford, University Press, Oxford, England.)
36. White, J. D., Zaknoen, S. L., Kasten-Sportès, C., Top, L. E., Navarro-Roman, L., Nelson, D. L. and Waldmann, T. A. (1995). Infectious complications and immunodeficiency in patients with human T-cell lymphotropic viras I-associated adult T-cell leukemia/lymphoma. Cancer, 75, 1598-1607.